rs897471

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005529.7(HSPG2):​c.4508C>T​(p.Ala1503Val) variant causes a missense change. The variant allele was found at a frequency of 0.717 in 1,599,188 control chromosomes in the GnomAD database, including 413,470 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1503A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.70 ( 38067 hom., cov: 34)
Exomes 𝑓: 0.72 ( 375403 hom. )

Consequence

HSPG2
NM_005529.7 missense

Scores

4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 4.32

Publications

43 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
  • Schwartz-Jampel syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • Silverman-Handmaker type dyssegmental dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Schwartz-Jampel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.2454389E-6).
BP6
Variant 1-21864961-G-A is Benign according to our data. Variant chr1-21864961-G-A is described in ClinVar as Benign. ClinVar VariationId is 291236.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.864 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005529.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
NM_005529.7
MANE Select
c.4508C>Tp.Ala1503Val
missense
Exon 36 of 97NP_005520.4
HSPG2
NM_001291860.2
c.4511C>Tp.Ala1504Val
missense
Exon 36 of 97NP_001278789.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
ENST00000374695.8
TSL:1 MANE Select
c.4508C>Tp.Ala1503Val
missense
Exon 36 of 97ENSP00000363827.3P98160

Frequencies

GnomAD3 genomes
AF:
0.704
AC:
107084
AN:
152058
Hom.:
38063
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.613
Gnomad AMI
AF:
0.751
Gnomad AMR
AF:
0.771
Gnomad ASJ
AF:
0.752
Gnomad EAS
AF:
0.886
Gnomad SAS
AF:
0.568
Gnomad FIN
AF:
0.736
Gnomad MID
AF:
0.801
Gnomad NFE
AF:
0.732
Gnomad OTH
AF:
0.713
GnomAD2 exomes
AF:
0.732
AC:
160466
AN:
219192
AF XY:
0.724
show subpopulations
Gnomad AFR exome
AF:
0.612
Gnomad AMR exome
AF:
0.807
Gnomad ASJ exome
AF:
0.744
Gnomad EAS exome
AF:
0.892
Gnomad FIN exome
AF:
0.750
Gnomad NFE exome
AF:
0.735
Gnomad OTH exome
AF:
0.750
GnomAD4 exome
AF:
0.718
AC:
1039393
AN:
1447012
Hom.:
375403
Cov.:
68
AF XY:
0.715
AC XY:
514172
AN XY:
719032
show subpopulations
African (AFR)
AF:
0.605
AC:
20062
AN:
33172
American (AMR)
AF:
0.802
AC:
34870
AN:
43484
Ashkenazi Jewish (ASJ)
AF:
0.738
AC:
19109
AN:
25876
East Asian (EAS)
AF:
0.888
AC:
34640
AN:
39026
South Asian (SAS)
AF:
0.575
AC:
48423
AN:
84266
European-Finnish (FIN)
AF:
0.742
AC:
36246
AN:
48874
Middle Eastern (MID)
AF:
0.735
AC:
4209
AN:
5728
European-Non Finnish (NFE)
AF:
0.722
AC:
798794
AN:
1106770
Other (OTH)
AF:
0.720
AC:
43040
AN:
59816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
18974
37948
56923
75897
94871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19828
39656
59484
79312
99140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.704
AC:
107117
AN:
152176
Hom.:
38067
Cov.:
34
AF XY:
0.706
AC XY:
52535
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.612
AC:
25423
AN:
41526
American (AMR)
AF:
0.772
AC:
11806
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.752
AC:
2611
AN:
3472
East Asian (EAS)
AF:
0.886
AC:
4563
AN:
5152
South Asian (SAS)
AF:
0.568
AC:
2739
AN:
4824
European-Finnish (FIN)
AF:
0.736
AC:
7795
AN:
10596
Middle Eastern (MID)
AF:
0.803
AC:
236
AN:
294
European-Non Finnish (NFE)
AF:
0.732
AC:
49756
AN:
67984
Other (OTH)
AF:
0.711
AC:
1503
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1604
3208
4812
6416
8020
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
826
1652
2478
3304
4130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.729
Hom.:
106370
Bravo
AF:
0.704
TwinsUK
AF:
0.705
AC:
2613
ALSPAC
AF:
0.717
AC:
2762
ESP6500AA
AF:
0.620
AC:
2716
ESP6500EA
AF:
0.740
AC:
6349
ExAC
AF:
0.706
AC:
84444
Asia WGS
AF:
0.700
AC:
2434
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
2
Lethal Kniest-like syndrome (2)
-
-
2
Schwartz-Jampel syndrome (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.54
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.0024
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0000013
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
4.3
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-3.1
D
REVEL
Benign
0.15
Sift
Benign
0.056
T
Sift4G
Uncertain
0.031
D
Polyphen
1.0
D
Vest4
0.11
MPC
0.33
ClinPred
0.020
T
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.17
gMVP
0.52
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs897471; hg19: chr1-22191454; COSMIC: COSV65969427; COSMIC: COSV65969427; API